Tango Therapeutics, Inc. (TNGX) has a market capitalization of $2.94B and trades at $25.33. The 52-week range is 1.03-22.2.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -29.1, Earnings Per Share (EPS) of $-0.87, annual revenue of $62.38M.
The stock has a beta of 1.32, operates in the Healthcare sector.
